Applied Biotechnology Institute Inc.
San Luis Obispo, CA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1 Grand Ave Bldg 83-1D, San Luis Obispo, CA 93405, USA
- Website
- appliedbiotech.org
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Title - a mucosal prophylactic vaccine against coccidioidomycosis | National Institute of Allergy and Infectious Diseases (NIH) | $449,984 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Applied Biotechnology Institute Inc. is a biotechnology company with an innovative protein production platform that uses a proprietary animal-free system to develop products with health and environmental benefits. It is a for-profit, veteran-owned Subchapter S Corporation registered in SAM.gov.
Over the past few years, Applied Biotechnology Institute Inc. has received several federal grants for its work on developing alternative vaccine delivery methods and production systems. In 2021, the National Institute of Allergy and Infectious Diseases awarded the company a $1.47 million grant under the Allergy and Infectious Diseases Research program to develop a low-cost vaccine for Lyme disease delivered through genetically modified maize. The project aims to produce the OspA antigen in maize plants and administer it orally to mice through maize flour to evaluate the immune response and protective efficacy against Borrelia burgdorferi, the bacterium that causes Lyme disease. Immuno Technologies Inc. is a sub-awardee on this project, conducting mouse feeding studies and tick challenge experiments. In 2019, Applied Biotechnology Institute Inc. received two smaller grants from the USDA's National Institute of Food and Agriculture – one for $99,935 to develop orally-delivered fish vaccines and another for $99,523 to produce a candidate vaccine for avian coccidiosis in maize. These projects demonstrate the company's focus on developing plant-based vaccine production and oral delivery systems across various animal and human applications.
Quick answers
Is Applied Biotechnology Institute Inc. registered in SAM.gov?
Yes. Applied Biotechnology Institute Inc.'s SAM.gov registration is active through July 9, 2027.
What is Applied Biotechnology Institute Inc.'s CAGE code?
Applied Biotechnology Institute Inc.'s CAGE code is 4A1R9, and its Unique Entity ID (UEI) is XNMLFC55AWN3.
What is Applied Biotechnology Institute Inc.'s most recent federal award?
Applied Biotechnology Institute Inc.'s most recent federal grant award is Production of low-cost heat stable forms of adalimumab in maize for treatment of inflammatory bowel disease (R43AI186801), from National Institute of Allergy and Infectious Diseases (NIH), on August 14, 2026.
On GovTribe
See Applied Biotechnology Institute Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors